Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Bayer

Investors Love Bayer, but the Courts Don’t – Buy, Sell, Hold?

Life sciences company Bayer (BAYRY) is currently facing a legal challenge concerning its Roundup. However, farmers have supported the company. On the other hand, despite the market volatility, the stock has been gaining in price. So, is the stock a Buy, Sell, or Hold now? Read on to find out….

StockNews.com

Smart Solutions For The World’s Serious Pesticide Problem

The post Smart solutions for the world’s serious pesticide problem appeared first on ISRAEL21c.

Zenger

While the world talked about Roe v Wade, the US Supreme Court was quietly reshaping the landscape in other ways

While the overturning of Roe v Wade has dominated headlines and sparked protests across the United States and elsewhere, it is not the only recent ruling to come from the highest court in America.

ABC News

From analysis to the latest developments in health,
read the most diverse news in one place.

The dangers of big data extend to farming

Most internet users are by now aware of the vulnerability of their personal data. When the news broke that tech companies misuse and manipulate our personal data, there was a widespread “techlash” against the corporate giants Facebook, Amazon and Google.

The Conversation

BWXT Medical, Bayer Ink Commercial Agreement For Actinium-225 Based Products

BWX Technologies Inc (NYSE:BWXT) subsidiary BWXT Medical Ltd. has entered a commercial agreement with Bayer AG (OTC:BAYRY) to supply high-purity Actinium-225 (Ac-225). Bayer will purchase high-purity Ac-225 from BWXT Medical at pre-determined prices. The parties expect supply to commence later this year. The above agreement follows the agreement reached by the parties in September 2021.…

Benzinga

Foreign Dividend Stocks Fuel This Red-Hot Mutual Fund

Share prices generally are down, so why not focus on something that works: dividend stocks? That's helped Europac International Dividend Income Fund.

Investors Business Daily

Trump's EPA carcinogen policy reversed

Why the controversial herbicide glyphosate, which some experts link to cancer, is under scrutiny once more

Salon

Read news from The Economist, FT, and more,
with one subscription

US Supreme Court rejects Bayer's appeal to stop Roundup weedkiller lawsuits

The Supreme Court has rejected Bayer's appeal to shut down thousands of lawsuits claiming that its Roundup weedkiller causes cancer.

France 24

Global stocks bounce after sharp selloff; yen falls

New York (AFP) - Stock markets rose Tuesday as calm returned following last week's rout, but analysts warned that recession fears have not gone away and will cause more turmoil.

AFP

US high court denies Bayer bid to block Roundup weedkiller lawsuits

Washington (AFP) - The US Supreme Court on Tuesday declined an appeal from Bayer-owned Monsanto that aimed to challenge thousands of lawsuits claiming its weedkiller Roundup causes cancer -- a potentially costly ruling.

AFP

Supreme Court rejects Bayer bid to stop lawsuits accusing Roundup brand weedkiller of causing cancer

Bayer inherited Roundup and the litigation when it acquired Monsanto in 2018

The Independent UK

Supreme Court rejects Bayer bid to stop Roundup lawsuits

The Supreme Court has rejected Bayer’s appeal to shut down thousands of lawsuits claiming that its Roundup weedkiller causes cancer

The Independent UK

Court rejects Trump-era EPA finding that weed killer safe

A federal appeals court has rejected a Trump administration finding that the active ingredient in the weed killer Roundup does not pose a serious health risk and is “not likely” to cause cancer in humans

The Independent UK

The farmers restoring Hawaii’s ancient food forests that once fed an island

Maui is a hub for GMO research but Indigenous farmers are trying to bring back the abundant and thriving landscapes of their ancestors

The Guardian - US

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Morning Brief: Top Financial Stories Dominating on Friday, June 10

Reuters Rebranded McDonald’s Restaurants To Reopen In Russia

Benzinga

US Top Court To Decide On Bayer's Roundup Weedkiller Appeal

The U.S. Supreme Court will likely reveal its decision over offering a clean chit to Bayer A.G.'s (OTC:BAYZF) Roundup weedkiller, Reuters reports. Bayer sought the review of an appeals court that sustained $25 million in damages awarded to a user of glyphosate-based weedkiller Roundup, who blamed his cancer on the product. Bayer urged…

Reuters

U.S. Supreme Court will soon decide whether to hear Bayer's weedkiller case

The U.S. Supreme Court could announce as soon as Monday whether it will hear Bayer's bid to dismiss claims its Roundup weedkiller causes cancer as the company seeks to avoid potentially billions of dollars more in damages and payouts.

The Guardian - UK

EU regulators ‘dismissed evidence’ linking glyphosate to rodent tumours

European Chemical Agency’s positive assessment for continued sale of substance is flawed, say environmental campaigners

Get all your
news in one place.

100’s of premium titles.
One news app.

Daily Mirror

Arsenal miss out on Mikel Arteta striker target as familiar problem emerges

Mikel Arteta's Arsenal are looking to sign at least one new centre-forward this summer after missing out on Champions League qualification to bitter rivals Tottenham

Benzinga

The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara

Here's a roundup of top developments in the biotech space over the last 24 hours:

Investors Business Daily

How Heart Drugs Could Pump $10 Billion Into Merck's Coffers

Merck stock has reinvigorated on the company's plans in heart disease. Will its efforts be enough as Keytruda goes off patent?

The Conversation

Considering an IUD but worried about pain during insertion? Here’s what to expect

Intrauterine devices (IUDs) are small T-shaped plastic devices containing either copper or a low dose of progestogen hormone. Lasting five to ten years, they provide highly effective contraception and are chosen by increasing numbers of users of all ages from adolescence to perimenopause.

Bangkok Post

Post-pandemic healthcare

Health crises and emergencies such as Covid-19 have brought into sharp focus the critical need for preparedness. The unprecedented pandemic has led to a dynamically changing environment across the healthcare industry, posing challenges that call for innovative solutions.

The Conversation

Medical societies and health-care companies may be too close for comfort

There are three different types of organizations for doctors in Canada: ones that license doctors to be able to practise and ensure that they are competent; ones that develop programs to train family doctors and specialists; and medical societies.

The Conversation

Why wealthy countries and companies need to do more to clean up global toxic chemical pollution

Keeping the environment safe is a shared responsibility between nations. But when it comes to harmful substances, especially persistent organic pollutants, advanced industrial nations should put more effort into reducing their global impacts.

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Arsenal

45,497 stories

UEFA Champions League

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.